Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certification & Accreditation
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: a review of real-world evidence (RWE)
By
- AMS
posted
Jan 28, 2020 09:51 AM
0
Recommend
Volume 32, Issue 8
, December 2021, Page 883-893
.
0 comments
1 view
Related Content
Cost per PASI-75 responder of calcipotriol plus betamethasone dipropionate cutaneous foam versus nonbiologic systemic therapies for the treatment of plaque psoriasis in seven European countries
- AMS
Added Mar 06, 2020
Blog Entry
A systematic review of evidence based treatments for lichen simplex chronicus
- AMS
Added Mar 06, 2020
Blog Entry
Characterization of insufficient responders to ustekinumab in patients with moderate-to-severe psoriasis in the US Corrona Psoriasis Registry
- AMS
Added Feb 28, 2020
Blog Entry
Concomitant atopic dermatitis and psoriasis – a retrospective review
- AMS
Added Dec 18, 2019
Blog Entry
Treatment of sebaceous gland hyperplasia: a review of the literature
- AMS
Added Apr 13, 2020
Blog Entry
Permalink
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic